Trial of Germany’s CureVac vaccine shows only 47% effect against Covid-19, falling short of great expectations ...News

Russia Today - News
Trial of Germany’s CureVac vaccine shows only 47% effect against Covid-19, falling short of great expectations
Praised just recently as “hope for the unvaccinated world,” a Covid-19 vaccine developed by Germany’s CureVac is only 47% effective against the coronavirus. As its stock collapsed, the company blamed new virus variants. Preliminary results from second and third-phase trials on 40,000 subjects in 10 countries of Europe and Latin America show that CureVac’s jab “did not meet pre-specified statistical success criteria,” the company announced on Wednesday. “In the unprecedented context of at least 13 variants circulating within the study population subset assessed at this interim analysis, CVnCoV demonstrated an interim vaccine efficacy of

Hence then, the article about trial of germany s curevac vaccine shows only 47 effect against covid 19 falling short of great expectations was published today ( ) and is available on Russia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Trial of Germany’s CureVac vaccine shows only 47% effect against Covid-19, falling short of great expectations )

Apple Storegoogle play

Last updated :

Also on site :



Latest News